426 related articles for article (PubMed ID: 19843243)
1. Dormancy of metastatic melanoma.
Ossowski L; Aguirre-Ghiso JA
Pigment Cell Melanoma Res; 2010 Feb; 23(1):41-56. PubMed ID: 19843243
[TBL] [Abstract][Full Text] [Related]
2. Focus on cutaneous and uveal melanoma specificities.
Pandiani C; Béranger GE; Leclerc J; Ballotti R; Bertolotto C
Genes Dev; 2017 Apr; 31(8):724-743. PubMed ID: 28512236
[TBL] [Abstract][Full Text] [Related]
3. Uveal melanoma dormancy: an acceptable clinical endpoint?
Blanco PL; Lim LA; Miyamoto C; Burnier MN
Melanoma Res; 2012 Oct; 22(5):334-40. PubMed ID: 22895346
[TBL] [Abstract][Full Text] [Related]
4. Oncogene status as a diagnostic tool in ocular and cutaneous melanoma.
Griewank KG; Schilling B; Scholz SL; Metz CH; Livingstone E; Sucker A; Möller I; Reis H; Franklin C; Cosgarea I; Hillen U; Steuhl KP; Schadendorf D; Westekemper H; Zimmer L
Eur J Cancer; 2016 Apr; 57():112-7. PubMed ID: 26918736
[TBL] [Abstract][Full Text] [Related]
5. Uveal Melanoma Nuclear BRCA1-Associated Protein-1 Immunoreactivity Is an Indicator of Metastasis.
Szalai E; Wells JR; Ward L; Grossniklaus HE
Ophthalmology; 2018 Feb; 125(2):203-209. PubMed ID: 28823399
[TBL] [Abstract][Full Text] [Related]
6. Genetic factors in metastatic progression of cutaneous melanoma: the future role of circulating melanoma cells in prognosis and management.
Ireland A; Millward M; Pearce R; Lee M; Ziman M
Clin Exp Metastasis; 2011 Apr; 28(4):327-36. PubMed ID: 21311956
[TBL] [Abstract][Full Text] [Related]
7. Uveal melanoma.
Jager MJ; Shields CL; Cebulla CM; Abdel-Rahman MH; Grossniklaus HE; Stern MH; Carvajal RD; Belfort RN; Jia R; Shields JA; Damato BE
Nat Rev Dis Primers; 2020 Apr; 6(1):24. PubMed ID: 32273508
[TBL] [Abstract][Full Text] [Related]
8. Roles of stem cell factor/c-Kit and effects of Glivec/STI571 in human uveal melanoma cell tumorigenesis.
Lefevre G; Glotin AL; Calipel A; Mouriaux F; Tran T; Kherrouche Z; Maurage CA; Auclair C; Mascarelli F
J Biol Chem; 2004 Jul; 279(30):31769-79. PubMed ID: 15145934
[TBL] [Abstract][Full Text] [Related]
9. Uveal melanoma: the good and the bad.
Hadden PW
Clin Exp Ophthalmol; 2008 Apr; 36(3):203. PubMed ID: 18412585
[No Abstract] [Full Text] [Related]
10. Lack of BRAF mutations in uveal melanoma.
Rimoldi D; Salvi S; Liénard D; Lejeune FJ; Speiser D; Zografos L; Cerottini JC
Cancer Res; 2003 Sep; 63(18):5712-5. PubMed ID: 14522889
[TBL] [Abstract][Full Text] [Related]
11. A metastasis modifier locus on human chromosome 8p in uveal melanoma identified by integrative genomic analysis.
Onken MD; Worley LA; Harbour JW
Clin Cancer Res; 2008 Jun; 14(12):3737-45. PubMed ID: 18559591
[TBL] [Abstract][Full Text] [Related]
12. Unveiling cancer dormancy: Intrinsic mechanisms and extrinsic forces.
Liu R; Zhao Y; Su S; Kwabil A; Njoku PC; Yu H; Li X
Cancer Lett; 2024 Jun; 591():216899. PubMed ID: 38649107
[TBL] [Abstract][Full Text] [Related]
13. Driver Mutations in Uveal Melanoma: Associations With Gene Expression Profile and Patient Outcomes.
Decatur CL; Ong E; Garg N; Anbunathan H; Bowcock AM; Field MG; Harbour JW
JAMA Ophthalmol; 2016 Jul; 134(7):728-33. PubMed ID: 27123562
[TBL] [Abstract][Full Text] [Related]
14. Association of Uveal Melanoma Metastatic Rate With Stochastic Mutation Rate and Type of Mutation.
Szalai E; Jiang Y; van Poppelen NM; Jager MJ; de Klein A; Kilic E; Grossniklaus HE
JAMA Ophthalmol; 2018 Oct; 136(10):1115-1120. PubMed ID: 30073324
[TBL] [Abstract][Full Text] [Related]
15. Uveal Melanomas Harbor Recurrent Activating Mutations in CYSLTR2.
Cancer Discov; 2016 Jun; 6(6):573. PubMed ID: 27150534
[TBL] [Abstract][Full Text] [Related]
16. Regulation of Metastatic Tumor Dormancy and Emerging Opportunities for Therapeutic Intervention.
Tamamouna V; Pavlou E; Neophytou CM; Papageorgis P; Costeas P
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430404
[TBL] [Abstract][Full Text] [Related]
17. The genetic basis of uveal melanoma.
Nielsen M; Dogrusöz M; Bleeker JC; Kroes WG; van Asperen CA; Marinkovic M; Luyten GP; Jager MJ
J Fr Ophtalmol; 2015 Jun; 38(6):516-21. PubMed ID: 25976137
[TBL] [Abstract][Full Text] [Related]
18. Skin metastases in metastatic uveal melanoma: GNAQ/GNA11 mutational analysis as a valuable tool.
Tsianakas A; Böhm MR; Getova V; Metze D; Eter N; Spieker T; Bräuninger A; Luger T; Schiller M; Sunderkötter C
Br J Dermatol; 2013 Jul; 169(1):160-3. PubMed ID: 23464620
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic reprogramming and aberrant expression of PRAME are associated with increased metastatic risk in Class 1 and Class 2 uveal melanomas.
Field MG; Durante MA; Decatur CL; Tarlan B; Oelschlager KM; Stone JF; Kuznetsov J; Bowcock AM; Kurtenbach S; Harbour JW
Oncotarget; 2016 Sep; 7(37):59209-59219. PubMed ID: 27486988
[TBL] [Abstract][Full Text] [Related]
20. [Expression of EphA2 in Metastatic and Non-Metastatic Primary Uveal Melanoma].
Vukoja V; Brandenbusch T; Tura A; Nassar K; Rohrbach DJ; Lüke M; Grisanti S; Lüke J
Klin Monbl Augenheilkd; 2016 Mar; 232(3):290-7. PubMed ID: 26854480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]